Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
81.57
+5.81 (7.67%)
At close: May 12, 2025, 4:00 PM
81.56
-0.01 (-0.01%)
After-hours: May 12, 2025, 7:59 PM EDT
Illumina Employees
Illumina had 10,370 employees as of December 31, 2024. The number of employees decreased by 2,020 or -16.30% compared to the previous year.
Employees
10,370
Change (1Y)
-2,020
Growth (1Y)
-16.30%
Revenue / Employee
$418,226
Profits / Employee
-$93,153
Market Cap
12.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
Dec 31, 2023 | 12,390 | -970 | -7.26% |
Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
Dec 29, 2019 | 7,700 | 400 | 5.48% |
Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
Dec 31, 2017 | 6,200 | 700 | 12.73% |
Dec 31, 2016 | 5,500 | 900 | 19.57% |
Dec 31, 2015 | 4,600 | 900 | 24.32% |
Dec 28, 2014 | 3,700 | 700 | 23.33% |
Dec 29, 2013 | 3,000 | 800 | 36.36% |
Dec 31, 2012 | 2,200 | -200 | -8.33% |
Dec 30, 2012 | 2,400 | 300 | 14.29% |
Dec 31, 2011 | 2,100 | 319 | 17.91% |
Dec 31, 2010 | 1,781 | 245 | 15.95% |
Dec 28, 2008 | 1,536 | 495 | 47.55% |
Dec 30, 2007 | 1,041 | 445 | 74.66% |
Dec 31, 2006 | 596 | 221 | 58.93% |
Dec 31, 2006 | 375 | 97 | 34.89% |
Dec 31, 2005 | 278 | 42 | 17.80% |
Dec 28, 2003 | 236 | 3 | 1.29% |
Dec 29, 2002 | 233 | 54 | 30.17% |
Dec 30, 2001 | 179 | 74 | 70.48% |
Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ILMN News
- 9 hours ago - Illumina Analysts Lower Their Forecasts After Q1 Results - Benzinga
- 1 day ago - Illumina: Multiple Headwinds Point To Limited Upside In 2025 - Seeking Alpha
- 3 days ago - Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development - PRNewsWire
- 24 days ago - Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong Portfolios - GlobeNewsWire
- 27 days ago - Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PRNewsWire
- 4 weeks ago - Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 - PRNewsWire
- 6 weeks ago - Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders - CNBC